BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27637901)

  • 21. Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas.
    Yang I; Nagasawa DT; Kim W; Spasic M; Trang A; Lu DC; Martin NA
    J Clin Neurosci; 2012 Jun; 19(6):779-85. PubMed ID: 22516549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adult Spinal Ependymomas: An Epidemiologic Study.
    Khalid SI; Adogwa O; Kelly R; Metha A; Bagley C; Cheng J; O'Toole J
    World Neurosurg; 2018 Mar; 111():e53-e61. PubMed ID: 29225135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intracranial intrarachindial ependymomas. Preface].
    Goutelle A; Fischer G
    Neurochirurgie; 1977 May; 23 Suppl 1():5-6. PubMed ID: 593491
    [No Abstract]   [Full Text] [Related]  

  • 24. Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas.
    Birch BD; Johnson JP; Parsa A; Desai RD; Yoon JT; Lycette CA; Li YM; Bruce JN
    Neurosurgery; 1996 Jul; 39(1):135-40. PubMed ID: 8805149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression alterations define unique molecular characteristics of spinal ependymomas.
    Lourdusamy A; Rahman R; Grundy RG
    Oncotarget; 2015 Aug; 6(23):19780-91. PubMed ID: 25909290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of chromosome 7 in adult and pediatric ependymomas using chromogenic in situ hybridization.
    Santi M; Quezado M; Ronchetti R; Rushing EJ
    J Neurooncol; 2005 Mar; 72(1):25-8. PubMed ID: 15803371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Frequency and morphology of supratentorial ependymomas in adults].
    Minauf M; Jellinger K; Grunert V
    Acta Neurochir (Wien); 1970; 22(2):181-93. PubMed ID: 5521229
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative analysis between multi-segments intramedullary spinal cord congenital tumors and benign ependymomas].
    Sun JJ; Wang ZY; Xie JC; Li ZD; Ma CC; Liu B; Zhao JZ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 42(2):183-7. PubMed ID: 20396361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets.
    Nagasawa DT; Trang A; Choy W; Spasic M; Yew A; Zarinkhou G; Garcia HM; Yang I
    Clin Neurol Neurosurg; 2013 Apr; 115(4):388-99. PubMed ID: 23374238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ependymomas in Children and Adults.
    Lampros M; Vlachos N; Alexiou GA
    Adv Exp Med Biol; 2023; 1405():99-116. PubMed ID: 37452936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.
    Korshunov A; Neben K; Wrobel G; Tews B; Benner A; Hahn M; Golanov A; Lichter P
    Am J Pathol; 2003 Nov; 163(5):1721-7. PubMed ID: 14578171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of nervous system tumors.
    Shapiro JR
    Hematol Oncol Clin North Am; 2001 Dec; 15(6):961-77. PubMed ID: 11770302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma.
    Friedrich C; von Bueren AO; Kolevatova L; Bernreuther C; Grob T; Sepulveda-Falla D; van den Boom L; Westphal M; Simon R; Glatzel M
    Childs Nerv Syst; 2016 Feb; 32(2):281-90. PubMed ID: 26686534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial differentiation and proliferative potential in spinal ependymomas.
    Takeuchi H; Kubota T; Sato K; Llena JF; Hirano A
    J Neurooncol; 2002 May; 58(1):13-9. PubMed ID: 12160136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas.
    Rousseau-Merck M; Versteege I; Zattara-Cannoni H; Figarella D; Lena G; Aurias A; Vagner-Capodano AM
    Cancer Genet Cytogenet; 2000 Sep; 121(2):223-7. PubMed ID: 11063814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A deletion causing NF2 exon 9 skipping is associated with familial autosomal dominant intramedullary ependymoma.
    Zemmoura I; Vourc'h P; Paubel A; Parfait B; Cohen J; Bilan F; Kitzis A; Rousselot C; Parker F; François P; Andres CR
    Neuro Oncol; 2014 Jan; 16(2):250-5. PubMed ID: 24357459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ependymoma: Evaluation and Management Updates.
    Rudà R; Bruno F; Pellerino A; Soffietti R
    Curr Oncol Rep; 2022 Aug; 24(8):985-993. PubMed ID: 35384591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
    Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
    J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.
    Palm T; Figarella-Branger D; Chapon F; Lacroix C; Gray F; Scaravilli F; Ellison DW; Salmon I; Vikkula M; Godfraind C
    Cancer; 2009 Sep; 115(17):3955-68. PubMed ID: 19536879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options.
    Dorfer C; Tonn J; Rutka JT
    Handb Clin Neurol; 2016; 134():417-31. PubMed ID: 26948369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.